Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1979-08-21
1981-11-03
Kyle, Deborah L.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 260112B, 424 12, 435 7, A61K 4300, G01N 3348, G01T 100
Patent
active
042985935
ABSTRACT:
This invention involves an improvement in a method for immunochemically assaying a member of an antigen-antibody binding pair in serum or plasma which utilizes labeled antigen having a plurality of antigenic binding sites as the indicating reagent, the improvement comprising employing the antigen immunochemically bound to labeled Fab as the indicating reagent. This invention also encompasses reagents useful in practicing the above method. These methods and reagents are particularly useful in hepatitis detection.
REFERENCES:
patent: 4166106 (1979-08-01), Sedlacek et al.
patent: 4193982 (1980-03-01), Avrameas et al.
Gonatas et al., J. Histochem. Cytochem., 22 #11 1974, pp. 999-1009.
Zaitlin, Immunochem., 8(6) 1971, pp. 569-573._
Abbott Laboratories
Kyle Deborah L.
McDonnell John J.
Nucker Christine M.
LandOfFree
Reagents and methods utilizing labeled Fab bound to antigens does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reagents and methods utilizing labeled Fab bound to antigens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reagents and methods utilizing labeled Fab bound to antigens will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1064359